Drug delivery, medicinal research, catalysis, and other fields may all benefit greatly from silver nanoparticles (AgNPs). Therapeutic AgNPs are in high demand across the world, thus several companies are now synthesising them. These materials may be manufactured at low cost but not without risk due to the use of chemical processes. These processes also pollute the environment, create dangerous byproducts, and have other concerning features. Nanomaterial synthesis that is mediated by plant extracts is gaining popularity as a method to fabricate nanomaterials with consistent size and shape.